Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors

Haemophilia. 2016 Jan;22(1):e71-4. doi: 10.1111/hae.12857. Epub 2015 Nov 27.
No abstract available

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Clinical Trials as Topic
  • Drug Combinations
  • Factor VIII / pharmacology*
  • Factor VIII / therapeutic use*
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology*
  • Humans
  • Immune Tolerance / drug effects*
  • von Willebrand Factor / pharmacology*
  • von Willebrand Factor / therapeutic use*

Substances

  • Drug Combinations
  • factor VIII, von Willebrand factor drug combination
  • von Willebrand Factor
  • Factor VIII